Related Experiment Video
Updated: Aug 17, 2026

A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation
Published on: April 2, 2012
Oral acyclovir for herpes zoster: a double-blind controlled trial in normal subjects
S W Wassilew1, S Reimlinger, T Nasemann
1University of Hamburg, UKE Hautklinik, FRG.
Abstract:
Sixty immunocompetent patients with herpes zoster of various dermatomes were treated 5 times a day for 5 days with either acyclovir at a dose of 400 mg or placebo. Acyclovir was shown to reduce significantly the time to full crusting (P = 0.02). There were also trends in favour of acyclovir for time to first dry vesicle and time to first day without macules or papules, but these were not statistically significant. There were no differences between the groups in the occurrence of adverse events or postherpetic neuralgia.
Related Concept Videos
DNA Base Pairing
Bioavailability Study Design: Healthy Subjects Versus Patients
Herpes
Chickenpox
Genital Herpes
Antiviral Nucleoside Inhibitors

